Total planned funding: $61,615,864
Allocations
Countries/Regions
| Central Asia Region | $61,615,864 |
Organizational Types
| Own Agency | $17,910,860 |
| Unknown | $15,315,035 |
| University | $9,576,700 |
| NGO | $8,003,170 |
| Host Country Government Agency | $6,207,870 |
| Private Contractor | $3,632,129 |
| Multi-lateral Agency | $745,000 |
| Implementing Agency | $167,000 |
| Other USG Agency | $58,100 |
Program Areas
| Prevention | $19,348,189 |
| Governance and Systems | $12,620,984 |
| Management and Operations | $12,350,444 |
| Care | $8,082,267 |
| Testing | $5,110,783 |
| Treatment | $4,103,197 |
Budget Codes
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $13,732,140 |
| HVMS: Management and Operations | $12,350,444 |
| HBHC: Care: Adult Care and Support | $6,655,026 |
| HVCT: Testing: HIV Testing and Counseling | $5,110,783 |
| HLAB: Laboratory Infrastructure | $4,307,646 |
| HVSI: Strategic Information | $4,169,535 |
| OHSS: Health Systems Strengthening | $4,143,803 |
| HTXS: Treatment: Adult Treatment | $4,070,028 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $3,976,522 |
| HVTB: Care: TB/HIV | $1,427,241 |
| HMBL: Biomedical Prevention: Blood Safety | $1,215,461 |
| HMIN: Biomedical Prevention: Injection Safety | $424,066 |
| HTXD: Treatment: ARV Drugs | $33,169 |
Top Partner Programs
Not Available:
$15,215,035
Countries/Regions
Central Asia Region
| 2011 | $1,092,788 |
| 2012 | $1,913,199 |
| 2014 | $7,315,722 |
| 2015 | $4,893,326 |
USG Aggregated Agencies:
$12,548,497
Countries/Regions
Central Asia Region
| 2011 | $5,099,999 |
| 2012 | $1,121,824 |
| 2015 | $4,926,674 |
| 2017 | $1,400,000 |
Columbia University:
$9,576,700
Countries/Regions
Abt Associates:
$3,632,129
Countries/Regions
Central Asia Region
| 2011 | $2,232,129 |
| 2012 | $0 |
| 2014 | $1,400,000 |
| 2015 | $0 |